| 发明名称 |
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TUMORS EXPRESSING EGFR AND GM3 N-GLYCOLYL GANGLIOSIDE (NeuGcGM3) |
| 摘要 |
The present invention relates to pharmaceutical compositions for the treatment of malignant tumors. Particularly those tumors that express EGFR and GM3 N-glycolyl ganglioside targets to enhance the therapeutic effect produced by separated therapies against these targets. The pharmaceutical compositions of the invention include antibodies and/or vaccines against each of the targets. Additionally the present invention relates to methods for applying the compositions of the invention. |
| 申请公布号 |
US2014363494(A1) |
申请公布日期 |
2014.12.11 |
| 申请号 |
US201214369435 |
申请日期 |
2012.12.04 |
| 申请人 |
CENTRO DE INMUNOLOGIA MOLECULAR |
发明人 |
González Palomo Adys;Carr Perez Adriana;León Monzón Kalet;Blanco Santana Rancés;Barroso Alvarez María del Carmen;Macías Abraham Amparo Emilia;Montero Casimiro José Enrique |
| 分类号 |
C07K16/28;A61K39/00;A61K39/395;C07K16/30 |
主分类号 |
C07K16/28 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A composition that comprises a compound against EGF receptor and a compound against the NeuGcGM3 ganglioside for use in the treatment of cancer. |
| 地址 |
La Habana CU |
